Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Liverpool Women's Hospital NHS Foundation Trust, Liverpool, UK.
Hum Reprod. 2019 Jan 1;34(1):56-68. doi: 10.1093/humrep/dey336.
STUDY QUESTION: Is endometriosis associated with abnormally located endometrial basalis-like (SSEA1+/SOX9+) cells in the secretory phase functionalis and could they contribute to ectopic endometriotic lesion formation? SUMMARY ANSWER: Women with endometriosis had an abnormally higher number of basalis-like SSEA1+/SOX9+ epithelial cells present in the stratum functionalis and, since these cells formed 3D structures in vitro with phenotypic similarities to ectopic endometriotic lesions, they may generate ectopic lesions following retrograde menstruation. WHAT IS KNOWN ALREADY: Endometrial basalis cells with progenitor potential are postulated to play a role in the pathogenesis of endometriosis and SSEA1 and nuclear SOX9 (nSOX9) mark basalis epithelial cells that also have some adenogenic properties in vitro. Induction of ectopic endometriotic lesions in a baboon model of endometriosis produces characteristic changes in the eutopic endometrium. Retrograde menstruation of endometrial basalis cells is proposed to play a role in the pathogenesis of endometriosis. STUDY DESIGN, SIZE, DURATION: This prospective study included endometrial samples from 102 women with and without endometriosis undergoing gynaecological surgery and from six baboons before and after induction of endometriosis, with in vitro assays examining the differentiation potential of human basalis-like cells. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was conducted at a University Research Institute. SSEA1 and SOX9 expression levels were examined in human endometrial samples from women aged 18-55 years (by immunohistochemistry (IHC) and qPCR) and from baboons (IHC). The differential gene expression and differentiation potential was assessed in freshly isolated SSEA1+ endometrial epithelial cells from women with and without endometriosis (n = 8/group) in vitro. In silico analysis of selected published microarray datasets identified differential regulation of genes of interest for the mid-secretory phase endometrium of women with endometriosis relative to that of healthy women without endometriosis. MAIN RESULTS AND THE ROLE OF CHANCE: Women with endometriosis demonstrated higher number of basalis-like cells (SSEA1+, nSOX9+) in the functionalis layer of the eutopic endometrium compared with the healthy women without endometriosis in the secretory phase of the cycle (P < 0.05). Induction of endometriosis resulted in a similar increase in basalis-like epithelial cells in the eutopic baboon endometrium. The isolated SSEA1+ epithelial cells from the eutopic endometrium of women with endometriosis had higher expression of OCT4, NANOG, FUT4 mRNA (P = 0.05, P = 0.007, P = 0.018, respectively) and they differentiated into ectopic endometriotic gland-like structures in 3D culture, but not into mesodermal lineages (adipose or bone cells). LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Small sample size. Bioinformatics analysis and results depends on the quality of published microarray datasets and the stringency of patient selection criteria employed. Differentiation of SSEA-1+ cells was only examined for two mesodermal lineages (adipogenic and osteogenic). WIDER IMPLICATIONS OF THE FINDINGS: Since endometrial epithelial cells with SSEA1+/nSOX9+ basalis-like phenotype generate endometriotic gland-like structures in vitro, they may potentially be a therapeutic target for endometriosis. An in depth analysis of the function of basalis-like eutopic endometrial epithelial cells might provide insights into their potential deregulation in other disorders of the endometrium including heavy menstrual bleeding and endometrial cancer where their function may be aberrant. STUDY FUNDING/COMPETING INTEREST(S): We acknowledge the support by Wellbeing of Women project grant RG1073 (D.K.H., C.E.G.) and R01 HD083273 from the National Institutes of Health (A.T.F.). We also acknowledge the support of Liverpool Women's Hospital Foundation Trust (J.D.), Institute of Translational Medicine (L.D.S., H.A.L., A.J.V., D.K.H.), University of Liverpool, the National Health and Medical Research Council of Australia ID 1042298 (C.E.G.) and the Victorian Government Operational Infrastructure Support Fund. All authors declare no conflict of interest.
研究问题:子宫内膜异位症是否与分泌期功能层中异常定位的子宫内膜基底样(SSEA1+/SOX9+)细胞有关,这些细胞是否有助于形成异位子宫内膜病灶?
总结答案:患有子宫内膜异位症的女性在功能层中存在异常数量的基底样 SSEA1+/SOX9+上皮细胞,并且由于这些细胞在体外形成具有与异位子宫内膜病灶相似表型的 3D 结构,它们可能会在逆行性月经后形成异位病灶。
已知情况:具有祖细胞潜能的子宫内膜基底细胞被认为在子宫内膜异位症的发病机制中起作用,SSEA1 和核 SOX9(nSOX9)标记体外也具有一些腺生成特性的基底上皮细胞。在子宫内膜异位症的狨猴模型中诱导异位子宫内膜病灶会导致在位子宫内膜发生特征性变化。逆行性月经期间的子宫内膜基底细胞被认为在子宫内膜异位症的发病机制中起作用。
研究设计、大小和持续时间:本前瞻性研究包括 102 名患有和不患有子宫内膜异位症的女性以及 6 只狨猴在接受妇科手术前和诱导子宫内膜异位症后的子宫内膜样本,通过体外检测人类基底样细胞的分化潜能来进行体外检测。
参与者/材料、设置、方法:该研究在大学研究所进行。通过免疫组织化学(IHC)和 qPCR 检测 18-55 岁女性(IHC)和狨猴(IHC)子宫内膜样本中 SSEA1 和 SOX9 的表达水平。从患有和不患有子宫内膜异位症的女性(每组 n=8)中分离出 SSEA1+子宫内膜上皮细胞,并在体外评估其差异基因表达和分化潜能。通过对患有子宫内膜异位症的女性和健康女性无子宫内膜异位症的子宫内膜的中分泌期进行微阵列数据集的生物信息学分析,确定了与健康女性相比,患有子宫内膜异位症的女性子宫内膜中感兴趣基因的差异调节。
主要结果和机会的作用:与健康女性无子宫内膜异位症相比,患有子宫内膜异位症的女性在分泌期的功能层中存在更多的基底样细胞(SSEA1+,nSOX9+)(P<0.05)。子宫内膜异位症的诱导导致在雌性狨猴的在位子宫内膜中也出现类似的基底样上皮细胞增加。从患有子宫内膜异位症的女性的在位子宫内膜中分离出的 SSEA1+上皮细胞中,OCT4、NANOG、FUT4 mRNA 的表达更高(P=0.05、P=0.007、P=0.018,分别),并且它们在 3D 培养中分化为异位子宫内膜样腺体结构,但不能分化为中胚层谱系(脂肪或骨细胞)。
大规模数据:无。
局限性、谨慎的原因:样本量小。生物信息学分析和结果取决于已发表的微阵列数据集的质量和患者选择标准的严格程度。SSEA-1+细胞的分化仅检查了两个中胚层谱系(脂肪生成和成骨)。
更广泛的影响:由于具有 SSEA1+/nSOX9+基底样表型的子宫内膜上皮细胞可在体外产生子宫内膜样腺体结构,因此它们可能成为子宫内膜异位症的潜在治疗靶点。对基底样在位子宫内膜上皮细胞功能的深入分析可能为了解其在包括月经过多和子宫内膜癌在内的其他子宫内膜疾病中的潜在失调提供见解,这些疾病的功能可能异常。
研究资金/竞争利益:我们感谢 Wellbeing of Women 项目 RG1073 赠款(D.K.H.、C.E.G.)和美国国立卫生研究院 R01 HD083273 的支持(A.T.F.)。我们还感谢利物浦妇女医院基金会信托基金(J.D.)、转化医学研究所(L.D.S.、H.A.L.、A.J.V.、D.K.H.)、利物浦大学、澳大利亚国立卫生和医学研究委员会 ID 1042298(C.E.G.)和维多利亚州政府运营基础设施支持基金的支持。所有作者均声明无利益冲突。
Hum Reprod. 2021-1-1
Mol Hum Reprod. 2019-2-1
Hum Reprod. 2019-3-1
Curr Issues Mol Biol. 2025-1-13
Front Med (Lausanne). 2024-11-15
Int J Mol Sci. 2024-5-27
Stem Cell Rev Rep. 2024-7
Genes Dis. 2022-8-31
JCI Insight. 2023-6-8
Int J Mol Sci. 2018-10-19
Best Pract Res Clin Obstet Gynaecol. 2018-2-8
J Mol Endocrinol. 2016-8
Int J Reprod Med. 2014
Hum Reprod Update. 2014-10-10